For research and educational purposes only. Not medical advice.
Pemvidutide Reference
Educational, not medical advice reference for Pemvidutide: GLP-1, Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also know…
Reference summary
Phase 2 and Phase 3 trial data exist; pepSmart displays pemvidutide only as trial-context educational content.
- Categories
- GLP-1, Fat Loss
- Aliases
- ALT-801, GLP-1/glucagon dual agonist
- Evidence posture
- human — Human trial data exist, but pemvidutide remains investigational — no FDA-approved drug label.
- Regulatory status
- Investigational. Pemvidutide is a GLP-1 / glucagon dual receptor agonist in Altimmune Phase 2/3 programs in MASH and obesity. There is no FDA-approved drug label.
- Content review status
- investigational verified